Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 476 participants.
Also called NCT01956201
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 476 participants
- Registry
-
NCT01956201
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01956201. Randomized; double masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
- Condition
- Mixed Hyperlipidemia
- Intervention (Drug)
- Atorvastatin 20mg
- Intervention (Drug)
- Fenofibrate 160mg
- Intervention (Other)
- Placebo (Fenofibrate 160 mg)
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct01956201- Content hash
613317b2cb75a832bc689e51f8414cc826b2ed273696ab404b718c10ef174442